Targeting RAC1 might be a potential therapeutic strategy for diabetic kidney disease: a Mendelian randomization study

Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K (2023) Molecular pathways that drive diabetic kidney disease. J Clin Investig 133:e165654

Article  PubMed  CAS  PubMed Central  Google Scholar 

Johansen KL, Chertow GM, Foley RN et al (2021) US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 77:A7–A8

Article  PubMed  PubMed Central  Google Scholar 

Blazek O, Bakris GL (2023) Slowing the progression of diabetic kidney disease. Cells 12:1975

Article  PubMed  CAS  PubMed Central  Google Scholar 

Danta CC, Boa AN, Bhandari S, Sathyapalan T, Xu SZ (2021) Recent advances in drug discovery for diabetic kidney disease. Expert Opin Drug Discov 16:447–461

Article  PubMed  CAS  Google Scholar 

Albakr RB, Sridhar VS, Cherney DZI (2023) Novel therapies in diabetic kidney disease and risk of hyperkalemia: a review of the evidence from clinical trials. Am J Kidney Dis 82:737–742

Article  PubMed  Google Scholar 

Zoccali C, Vanholder R, Massy ZA et al (2017) The systemic nature of CKD. Nat Rev Nephrol 13:344–358

Article  PubMed  Google Scholar 

Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12:2032–2045

Article  PubMed  CAS  PubMed Central  Google Scholar 

Steichen C, Hervé C, Hauet T, Bourmeyster N (2022) Rho GTPases in kidney physiology and diseases. Small GTPases 13:141–161

Article  PubMed  CAS  Google Scholar 

Mende CW, Samarakoon R, Higgins PJ (2023) Mineralocorticoid receptor-associated mechanisms in diabetic kidney disease and clinical significance of mineralocorticoid receptor antagonists. Am J Nephrol 54:50–61

Article  PubMed  CAS  Google Scholar 

Tung CW, Hsu YC, Shih YH, Chang PJ, Lin CL (2018) Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology (Carlton) 23:32–37

Article  PubMed  CAS  Google Scholar 

Yoshida S, Ishizawa K, Ayuzawa N et al (2014) Local mineralocorticoid receptor activation and the role of Rac1 in obesity-related diabetic kidney disease. Nephron Exp Nephrol 126:16–24

Article  PubMed  CAS  Google Scholar 

Azarova I, Klyosova E, Polonikov A (2023) Single nucleotide polymorphisms of the RAC1 gene as novel susceptibility markers for neuropathy and microvascular complications in type 2 diabetes. Biomedicines 11:981

Article  PubMed  CAS  PubMed Central  Google Scholar 

Walsh L, Reilly JF, Cornwall C et al (2021) Safety and efficacy of GFB-887, a TRPC5 channel inhibitor, in patients with focal segmental glomerulosclerosis, treatment-resistant minimal change disease, or diabetic nephropathy: TRACTION-2 trial design. Kidney Int Rep 6:2575–2584

Article  PubMed  PubMed Central  Google Scholar 

Aman A, Slob EAW, Ward J et al (2022) Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization. PLoS ONE 17:e0279381

Article  PubMed  CAS  PubMed Central  Google Scholar 

Nica AC, Dermitzakis ET (2013) Expression quantitative trait loci: present and future. Philos Trans R Soc Lond B Biol Sci 368:20120362

Article  PubMed  PubMed Central  Google Scholar 

Cao Y, Yang Y, Hu Q, Wei G (2023) Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study. J Transl Med 21:616

Article  PubMed  CAS  PubMed Central  Google Scholar 

GTEx Consortium (2020) The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369:1318–1330

Article  Google Scholar 

Võsa U, Claringbould A, Westra HJ et al (2021) Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 53:1300–1310

Article  PubMed  PubMed Central  Google Scholar 

van Zuydam NR, Ahlqvist E, Sandholm N et al (2018) A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes. Diabetes 67:1414–1427

Article  PubMed  PubMed Central  Google Scholar 

Teumer A, Li Y, Ghasemi S et al (2019) Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. Nat Commun 10:4130

Article  PubMed  PubMed Central  Google Scholar 

Elsworth B, Lyon M, Alexander T et al (2020) The MRC IEU OpenGWAS data infrastructure. bioRxiv. https://doi.org/10.1101/2020.08.10.244293

Article  Google Scholar 

Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50:693–698

Article  PubMed  CAS  PubMed Central  Google Scholar 

Burgess S, Dudbridge F, Thompson SG (2016) Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 35:1880–1906

Article  PubMed  Google Scholar 

Azarova I, Klyosova E, Polonikov A (2022) Association between RAC1 gene variation, redox homeostasis and type 2 diabetes mellitus. Eur J Clin Investig 52:e13792

Article  CAS  Google Scholar 

Hirohama D, Kawarazaki W, Nishimoto M et al (2020) PGI2Analog attenuates salt-induced renal injury through the inhibition of inflammation and Rac1-MR activation. Int J Mol Sci 21:4433

Article  PubMed  CAS  PubMed Central  Google Scholar 

Lv Z, Hu M, Fan M et al (2018) Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice. Cell Death Dis 9:342

Article  PubMed  PubMed Central  Google Scholar 

Apte M, Khan MS, Bangar N, Gvalani A, Naz H, Tupe RS (2023) Crosstalk between aldosterone and glycation through Rac-1 induces diabetic nephropathy. ACS Omega 8:37264–37273

Article  PubMed  CAS  PubMed Central  Google Scholar 

Ying C, Zhou Z, Dai J et al (2022) Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy. Inflamm Res 71:191–204

Article  PubMed  CAS  Google Scholar 

Ying C, Dai J, Fan G et al (2021) Ras-related C3 botulinum toxin substrate 1 combining with the mixed lineage kinase 3-mitogen-activated protein kinase 7-c-Jun N-terminal kinase signaling module accelerates diabetic nephropathy. Front Physiol 12:679166

Article  PubMed  PubMed Central  Google Scholar 

Xiong D, Hu W, Han X, Cai Y (2023) Rhein inhibited ferroptosis and EMT to attenuate diabetic nephropathy by regulating the Rac1/NOX1/β-catenin axis. Front Biosci (Landmark Ed) 28:100

Article  PubMed  CAS  Google Scholar 

García-Carro C, Vergara A, Bermejo S et al (2021) How to assess diabetic kidney disease progression? From albuminuria to GFR. J Clin Med 10:2505

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif